Virbac SA (VIRP.PA) — Technical state
As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 50 out of 100 (momentum 61 · quality 52 · valuation 55), as of 2026-11-11.
- Signal: Recovery attempt under the 200-day — Trades +9.4% vs the 50-day and +4.7% vs the 200-day average, 7.8% below the 52-week high and +20.4% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
- Trend: Virbac SA trades 9.4% above its 50-day and 4.7% above its 200-day moving average. (as of 2026-11-10)
Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VIRP.PA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +9.4% vs the 50-day and +4.7% vs the 200-day average, 7.8% below the 52-week high and +20.4% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+2.5%
- vs 50-day+9.4%
- vs 200-day+4.7%
- 52-week band7.8% off the high · +20.4% off the low
- Streak2 consecutive down sessions
- 50-day crossprice crossed up through the 50-day 20 sessions ago
- Stochastic%K 63 · %D 75.7
Continue: the VIRP.PA chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-10
Quick answers
What is the current Closelooknet signal on VIRP.PA?
Recovery attempt under the 200-day — Trades +9.4% vs the 50-day and +4.7% vs the 200-day average, 7.8% below the 52-week high and +20.4% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is VIRP.PA above its 50-day and 200-day moving averages?
As of 2026-11-10, Virbac SA trades +9.4% above its 50-day and +4.7% above its 200-day average, with the 20-day +2.5% away.
How far is VIRP.PA from its 52-week high?
7.8% below the 52-week high and 20.4% above the 52-week low, as of 2026-11-10.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AZN.L AstraZeneca PLCindustry
- GSK GSK plcindustry
- SNY Sanofi ADRindustry
- GILD Gilead Sciences Incindustry
- BIIB Biogen Incindustry
- ABBV AbbVie Incindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- JNJ Johnson & Johnsonindustry
- PFE Pfizer Incindustry
- BMY Bristol-Myers Squibb Companyindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- EL.PA EssilorLuxottica S. A.sector
- ABVX.PA Abivax SAsector